abstract |
The invention relates to novel antibodies, such as single-domain antibodies (sdAbs) or antigen-binding fragments thereof that specifically bind to a transferrin. The invention also provides compositions, methods and systems for increasing the half-life of a target protein in a serum using an antibody or fragment thereof directed against a transferrin. |